Navnita Dutta

机构：Jacksonville College, WinnMed, Cancer Clinic · ORCID：0000-0001-9683-6061

发表论文 21 篇 · 总被引 172 次 · h-index 6

代表论文

• Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy (2022 · Clinical Cancer Research · 被引 56)
• Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis (2020 · Clinical Lymphoma Myeloma & Leukemia · 被引 37)
• Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses (2020 · Blood Advances · 被引 37)
• Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade (2023 · Journal for ImmunoTherapy of Cancer · 被引 25)
• The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancers (2023 · Cancer Medicine · 被引 7)
• AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma (2023 · Cancers · 被引 6)